Home-Based Care for Advanced Kidney Disease
Trial Summary
What is the purpose of this trial?
This is a randomized pilot study to test the feasibility and acceptability of a novel conservative care (CC) pathway among patients with advanced chronic kidney disease (CKD) who have chosen to forgo initiation of maintenance dialysis, their caregivers and providers.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.
What data supports the effectiveness of the treatment Comprehensive Conservative Care for advanced kidney disease?
Research suggests that Comprehensive Conservative Care (CCC) can be a valid alternative to dialysis for certain patients with advanced kidney disease, particularly older individuals. Studies indicate that CCC may offer similar survival outcomes and potentially better quality of life compared to dialysis, focusing on symptom management and supportive care.12345
Is home-based care for advanced kidney disease safe for humans?
How is the Home-Based Care for Advanced Kidney Disease treatment different from other treatments?
This treatment, known as Comprehensive Conservative Care, is unique because it focuses on managing advanced kidney disease without dialysis, emphasizing quality of life and home-based care. It involves a holistic approach with a multidisciplinary team to support patients and caregivers, aiming to slow disease progression and prevent complications.13478
Research Team
Susan Wong, MD MS
Principal Investigator
VA Puget Sound Health Care System Seattle Division, Seattle, WA
Eligibility Criteria
This trial is for patients with advanced chronic kidney disease who have decided not to start maintenance dialysis. It's a pilot study to see if a new conservative care pathway works well and is accepted by patients, their caregivers, and healthcare providers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive the Kidney Care at Home Program through the existing HBPC infrastructure, involving multidisciplinary care and regular assessments.
Follow-up
Participants are monitored for safety and effectiveness after the intervention, including interviews and surveys to assess quality of life and care satisfaction.
Treatment Details
Interventions
- CC Program
CC Program is already approved in European Union, United States, Canada for the following indications:
- Advanced Chronic Kidney Disease (CKD)
- End-Stage Renal Disease (ESRD)
- Advanced Chronic Kidney Disease (CKD)
- End-Stage Renal Disease (ESRD)
- Advanced Chronic Kidney Disease (CKD)
- End-Stage Renal Disease (ESRD)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor